IDENTIFYING AND INDEXING DISCRIMINATIVE FEATURES FOR DISEASE PROGRESSION IN OBSERVATIONAL DATA

    公开(公告)号:US20190130070A1

    公开(公告)日:2019-05-02

    申请号:US15799664

    申请日:2017-10-31

    IPC分类号: G06F19/00 G06Q50/24

    摘要: A system (or method) for generation and employment of disease progression model(s) that facilitates identifying and indexing discriminative features for disease progression in observational data. The disease progression prediction system comprises a processor that executes computer executable components stored in memory. A receiving component receives and learns observational patient data. A model generation component builds a preliminary disease progression model. An identification component identifies discriminative clinical features for different disease stages. A ranking component ranks discriminative powers of clinical features for respective pairs of disease stages; wherein the model generation component employs the ranked features to generate a final disease progression model.

    Evidence Boosting in Rational Drug Design and Indication Expansion by Leveraging Disease Association

    公开(公告)号:US20170124469A1

    公开(公告)日:2017-05-04

    申请号:US14929995

    申请日:2015-11-02

    IPC分类号: G06N5/04 G06F19/12

    CPC分类号: G16B5/00 G16C20/50

    摘要: An embodiment of the invention receives input including a list of drugs, drug characteristics of each drug, and known drug-disease associations including a disease and a drug having a threshold efficacy for treating the disease. For each drug in the list of drugs, a processor predicts whether the drug meets a threshold efficacy for treating a first disease based on the drug characteristics and the drug-disease associations. For each drug in the list of drugs, the processor predicts whether the drug meets a threshold efficacy for treating a second disease based on the drug characteristics and the predicting of whether the drug meets the threshold efficacy for treating the first disease. Output is generated output based on the predictions, the output including an identified drug-disease association, an identified disease-disease association, an identified chemical fingerprint for the first disease, and an identified chemical fingerprint for the second disease.

    Enhanced DeepQA in a Medical Environment
    9.
    发明申请
    Enhanced DeepQA in a Medical Environment 有权
    增强DeepQA在医疗环境

    公开(公告)号:US20140058986A1

    公开(公告)日:2014-02-27

    申请号:US14067416

    申请日:2013-10-30

    IPC分类号: G06N5/02 G06N99/00

    摘要: A DeepQA engine is enhanced to provide a digital medical investigation tool which assists a medical professional in researching potential causes of a set of patient conditions, including clues, facts and factoids about the patient. The DeepQA engine provides one or more answers to a natural language question with confidence levels for each answer. If a confidence level falls below a threshold, the enhanced DeepQA engine performs a crowd sourcing operation to gather additional information from one or more domain experts. The domain expert responses are provided to the medical professional, and are learned by the enhanced DeepQA system to provide for better research of similar patient conditions in future queries.

    摘要翻译: DeepQA引擎被增强以提供数字医疗调查工具,其帮助医学专业人员研究一组病人状况的潜在原因,包括关于患者的线索,事实和事实。 DeepQA引擎为自然语言问题提供一个或多个答案,每个答案的置信水平。 如果置信水平低于阈值,则增强型DeepQA引擎执行群众采购操作,从一个或多个域专家收集附加信息。 领域专家的回答提供给医疗专业人员,并由增强型DeepQA系统学习,以提供对未来查询中类似患者状况的更好的研究。